Read more
2:33 PM · 5 May 2026

Palantir earnings: Just below expectations

Palantir released its results after Monday’s session ended. The numbers - good enough to put most companies to shame - ultimately came in just slightly below expectations.

One of the key efficiency metrics for SaaS companies that Palantir’s management emphasizes is the so‑called “Rule of 40.” In short, it means that the sum of a company’s annual revenue growth rate and its EBITDA margin should be around 40%.

For Palantir, this figure stands at roughly 58%, leaving nearly the entire tech sector behind and slightly outperforming Nvidia.

Looking at more conventional metrics:

  • Revenue: increased to $1.63 billion versus expected ~$1.55 billion.
    • Up 19% q/q and 85% y/y.
  • Adjusted EPS: rose to $0.33 versus expectations of ~$0.28.
    • Up 17% q/q and more than 250% y/y.
  • Adjusted FCF: increased to $924 million.

Guidance for Q2 2026 was set at:

  • Revenue: $1.79–$1.80 billion
  • Adjusted operating income: $1.063–$1.067 billion

On a full‑year basis, the company raised its outlook:

  • Revenue: $7.65 - $7.66 billion
  • U.S. commercial revenue: above $3.22 billion
  • Adjusted operating income: $4.4 - $4.45 billion
  • FCF: $4.2 - $4.4 billion

Despite this, the stock reacted with a modest decline of around 3%. So what didn’t land well?

Investor concerns focused on revenue in the U.S. commercial segment.

Sales grew 133% year over year, but came in below $600 million ($595 million), which was a moderate disappointment for the market. Concerns about the commercial segment are particularly important given the company’s increasing competitive pressure and market penetration by rivals.

PLTR.US (D1)

 

Source: xStation5

 

4 May 2026, 9:02 PM

Palantir preview: Another record or another sell-off?

30 April 2026, 1:03 AM

🤳Meta Delivers Powerful Results: Is it Still Not Enough for the Market?

30 April 2026, 12:59 AM

💻Microsoft Silences Skeptics with a Rain of Cash: Powerful Results for the Past Quarter

29 April 2026, 5:39 PM

Microsoft: Another Moment of Truth. Results After the Bell

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.